| scholarly article | Q13442814 |
| P50 | author | Clare E Bryant | Q58222548 |
| Nicholas J Gay | Q87612461 | ||
| Daniel R Levy | Q89947276 | ||
| P2093 | author name string | Panagiotis Tourlomousis | |
| Atul Udgata | |||
| Martyn F Symmons | |||
| Lee J Hopkins | |||
| P2860 | cites work | Identification of AXUD1, a novel human gene induced by AXIN1 and its reduced expression in human carcinomas of the lung, liver, colon and kidney | Q24291619 |
| Characterization of a family of novel cysteine- serine-rich nuclear proteins (CSRNP) | Q24338625 | ||
| Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration | Q24614960 | ||
| Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease | Q27015076 | ||
| LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase | Q27322966 | ||
| Parkinson's disease and immune system: is the culprit LRRKing in the periphery? | Q27687171 | ||
| A new mathematical model for relative quantification in real-time RT-PCR | Q27860781 | ||
| Endotoxin: is it an environmental factor in the cause of Parkinson's disease? | Q43066616 | ||
| Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells | Q43137963 | ||
| The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma | Q44029772 | ||
| The acute and the long-term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation. | Q46619925 | ||
| Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations | Q52014611 | ||
| Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development. | Q52656382 | ||
| A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. | Q54683068 | ||
| Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease | Q57629146 | ||
| edgeR: a Bioconductor package for differential expression analysis of digital gene expression data | Q27860819 | ||
| A novel treatment target for Parkinson's disease | Q28252840 | ||
| Axin, an inhibitor of the Wnt signalling pathway, interacts with β‐catenin, GSK‐3β and APC and reduces the β‐catenin level | Q28282155 | ||
| A common LRRK2 mutation in idiopathic Parkinson's disease | Q28304886 | ||
| The IkappaB kinase family phosphorylates the Parkinson's disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling | Q28480459 | ||
| Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: Structure, function and therapeutics | Q28608179 | ||
| Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation | Q28743193 | ||
| Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
| Chemokines: a new classification system and their role in immunity | Q29615663 | ||
| Protective and pathogenic functions of macrophage subsets | Q29620351 | ||
| Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms | Q30519552 | ||
| Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue | Q31028020 | ||
| Phosphorylation of ezrin/radixin/moesin proteins by LRRK2 promotes the rearrangement of actin cytoskeleton in neuronal morphogenesis | Q33595218 | ||
| PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification | Q33600700 | ||
| How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex | Q33797139 | ||
| TLR signaling paralyzes monocyte chemotaxis through synergized effects of p38 MAPK and global Rap-1 activation | Q34162512 | ||
| MAX and MYC: a heritable breakup | Q34282171 | ||
| Upregulation of GPR109A in Parkinson's disease | Q34361793 | ||
| GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor | Q34398451 | ||
| Viral parkinsonism. | Q34596492 | ||
| Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties | Q34629210 | ||
| LRRK2 is involved in the IFN-gamma response and host response to pathogens | Q35164433 | ||
| MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits | Q36004007 | ||
| Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo | Q36368755 | ||
| BPOZ-2 Gene Delivery Ameliorates Alpha-Synucleinopathy in A53T Transgenic Mouse Model of Parkinson's Disease | Q36621259 | ||
| Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition | Q36700166 | ||
| The Roco protein family: a functional perspective | Q37181600 | ||
| The role of HCA2 (GPR109A) in regulating macrophage function | Q37245946 | ||
| Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials | Q37937990 | ||
| Prediction of the repeat domain structures and impact of parkinsonism-associated variations on structure and function of all functional domains of leucine-rich repeat kinase 2 (LRRK2). | Q38182492 | ||
| Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. | Q38313431 | ||
| The chemokines CCR1 and CCRL2 have a role in colorectal cancer liver metastasis | Q38834435 | ||
| LRRK2 modulates microglial activity through regulation of chemokine (C-X3-C) receptor 1 -mediated signalling pathways | Q39732847 | ||
| The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells | Q40108303 | ||
| Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis | Q40238373 | ||
| Phosphoproteomic evaluation of pharmacological inhibition of leucine-rich repeat kinase 2 reveals significant off-target effects of LRRK-2-IN-1. | Q42263195 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| DESeq2 | Q113018293 | ||
| edgeR | Q113334690 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell adhesion | Q187640 |
| chemotaxis | Q658145 | ||
| P577 | publication date | 2020-02-28 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Parkinson's disease-associated kinase LRRK2 regulates genes required for cell adhesion, polarization, and chemotaxis in activated murine macrophages |
Search more.